JNK1 Antibodies

Santa Cruz Biotechnology features a diverse variety of JNK1 monoclonal antibodies for investigating c-Jun N-terminal kinase 1 (JNK1) in cellular processes. JNK1 monoclonal antibodies are suitable for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). JNK1 functions as a key component of the mitogen-activated protein kinase (MAPK) signaling pathway, regulating cellular responses to stress, inflammation, and apoptosis. JNK1 activation influences cell proliferation, differentiation, and survival mechanisms. Research has shown JNK1's significant role in cancer development, neurodegeneration, and metabolic disorders. Scientists can explore JNK1 signaling pathways using specific monoclonal antibodies conjugated with horseradish peroxidase (HRP), phycoerythrin (PE), or fluorescein isothiocyanate (FITC). Understanding JNK1's molecular mechanisms can advance therapeutic strategies for various diseases. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of JNK1's role in human health and disease.